Current Headlines

  1. Tecan Introduces Fluent Laboratory Automation Solution For Compound Management
    1/20/2015

    Tecan will soon be launching a new Fluent Laboratory Automation Solution designed to offer greater throughput and flexibility for compound management workflows*.

  2. BellBrook Labs Launches A High Throughput Screening Assay For Glycosyltransferases With TR-FRET Readout
    1/15/2015

    BellBrook Labs, a leader in high throughput screening assays for drug discovery, announced the launch of a TR-FRET (time resolved Forster resonance energy transfer) version of the company's Transcreener UDP Assay, a high throughput screening assay for glycosyltransferases and other UDP-producing enzymes.

  3. Adimab Announces New Partnerships With Acceleron, Oncothyreon, Surface Oncology And Potenza
    1/9/2015

    Adimab, LLC, the technology leader in the discovery of monoclonal and bispecific antibodies, recently announced independent discovery collaborations with Acceleron Pharma, Inc., Oncothyreon, Inc., Surface Oncology and Potenza Therapeutics, Inc.

  4. Biogen Idec And Columbia University Medical Center To Conduct Collaborative Genetics Research
    1/9/2015

    Biogen Idec and Columbia University Medical Center have formed a $30M strategic alliance to conduct genetics discovery research on the underlying causes of disease and to identify new treatment approaches.

  5. BioProcess Online Announces Inaugural Editorial Advisory Board
    1/6/2015

    To ensure we are providing readers with the content they will find timely and valuable, we rely on the feedback of pharma industry professionals and consultants to guide our focus and direction. With that in mind, we are proud to announce the launch of our inaugural editorial advisory board for the BioProcess Online website.

  6. Llamas Could Hold The Cure For HIV
    12/26/2014

    A collaboration between the University College London (UCL) and the Scripps Research Institute has found antibodies in the immune systems of llamas, which have the potential to create a HIV vaccine, Tech Times reports.

  7. Roche Buys Biotech Firm Dutalys And Bina Technologies
    12/26/2014

    Roche announced that it has entered into agreement to acquire Vienna-based, private biotech firm Dutalys and its proprietary DutaMab technology for the discovery and development of fully human, bi-specific antibodies.

  8. Novartis Links With BiolineRX To Develop Israel-Made Drugs
    12/26/2014

    Israeli clinical-stage biopharmaceutical company BioLineRX announced that it has signed up Swiss pharma giant Novartis in a multi-year strategic collaboration to develop and commercialize Israeli-sourced drug candidates.

  9. Tetraphase’s New Antibiotic Succeeds In Phase 3 Study
    12/26/2014

    Antibiotic maker Tetraphase has announced positive top-line results from the Phase 3 clinical trial of its novel antibiotic, eravacycline, for the treatment of complicated intra-abdominal infections (cIAI). The study (IGNITE 1) showed that eravacycline is as effective as Merck’s antibiotic, ertapenem.

  10. Researchers Discover New Antibodies Paving Way For Universal Dengue Vaccine
    12/23/2014

    A team of international researchers has made an important discovery that could lead to the development of the first universal dengue vaccine. The researchers, including groups from Australia, Vietnam, and London, have discovered a major new class of antibodies that neutralises all four different types of the deadly dengue virus.

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.